Nitrite, Isoquercetin and Endothelial Dysfunction (NICE) Trial
Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
The proposed randomized controlled trial will test the safety and efficacy of combination
therapy with sodium nitrite and isoquercetin on endothelial function and inflammation among
patients with chronic kidney disease.
Phase:
Phase 2
Details
Lead Sponsor:
Jing Chen Tulane University
Collaborator:
National Institute of General Medical Sciences (NIGMS)